Hepatitis E in Germany-an under-reported infectious disease

Standard

Hepatitis E in Germany-an under-reported infectious disease. / Pischke, Sven; Behrendt, Patrick; Bock, Claus-Thomas; Jilg, Wolfgang; Manns, Michael P; Wedemeyer, Heiner.

in: DTSCH ARZTEBL INT, Jahrgang 111, Nr. 35-36, 01.09.2014, S. 577-583.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Pischke, S, Behrendt, P, Bock, C-T, Jilg, W, Manns, MP & Wedemeyer, H 2014, 'Hepatitis E in Germany-an under-reported infectious disease', DTSCH ARZTEBL INT, Jg. 111, Nr. 35-36, S. 577-583. https://doi.org/10.3238/arztebl.2014.0577

APA

Pischke, S., Behrendt, P., Bock, C-T., Jilg, W., Manns, M. P., & Wedemeyer, H. (2014). Hepatitis E in Germany-an under-reported infectious disease. DTSCH ARZTEBL INT, 111(35-36), 577-583. https://doi.org/10.3238/arztebl.2014.0577

Vancouver

Pischke S, Behrendt P, Bock C-T, Jilg W, Manns MP, Wedemeyer H. Hepatitis E in Germany-an under-reported infectious disease. DTSCH ARZTEBL INT. 2014 Sep 1;111(35-36):577-583. https://doi.org/10.3238/arztebl.2014.0577

Bibtex

@article{474648c6b9f44ce39ee62820e2ac8995,
title = "Hepatitis E in Germany-an under-reported infectious disease",
abstract = "BACKGROUND: At least 17% of the population in Germany has been infected with the hepatitis E virus (HEV); thus, HEV infections are more frequent than was previously assumed. However, fewer than 500 HEV infections were reported to the Robert Koch Institute in 2013.METHOD: Review of pertinent literature retrieved by a selective search in PubMed.RESULTS: Persons living in Germany generally acquire hepatitis E infection within the country by consuming infected and undercooked pork; in rare cases, hepatitis E infections are imported from the tropics. HEV can be transmitted via blood products, blood transfusions, and organ transplantation. More than 99% of HEV infections are asymptomatic and self-limiting, but there are also severe cases with acute liver failure. Immunosuppressed persons can develop chronic HEV infection, potentially leading, within a few years, to liver cirrhosis with life-threatening sequelae. Moreover, HEV infection may be associated with extrahepatic manifestations such as Guillain-Barr{\'e} syndrome. In two retrospectively evaluated case series, ribavirin was found to be active against HEV and can be used to treat either acute or chronic HEV infection.CONCLUSION: Hepatitis E must be considered in the differential diagnosis of elevated hepatic enzyme levels and of systemic and neurological conditions of uncertain origin. The infection is usually self-limiting but can take a severe course in immunosuppressed persons. In such cases, ribavirin can be used as an antiviral treatment.",
author = "Sven Pischke and Patrick Behrendt and Claus-Thomas Bock and Wolfgang Jilg and Manns, {Michael P} and Heiner Wedemeyer",
year = "2014",
month = sep,
day = "1",
doi = "10.3238/arztebl.2014.0577",
language = "Deutsch",
volume = "111",
pages = "577--583",
journal = "DTSCH ARZTEBL INT",
issn = "1866-0452",
publisher = "Deutscher Arzte-Verlag",
number = "35-36",

}

RIS

TY - JOUR

T1 - Hepatitis E in Germany-an under-reported infectious disease

AU - Pischke, Sven

AU - Behrendt, Patrick

AU - Bock, Claus-Thomas

AU - Jilg, Wolfgang

AU - Manns, Michael P

AU - Wedemeyer, Heiner

PY - 2014/9/1

Y1 - 2014/9/1

N2 - BACKGROUND: At least 17% of the population in Germany has been infected with the hepatitis E virus (HEV); thus, HEV infections are more frequent than was previously assumed. However, fewer than 500 HEV infections were reported to the Robert Koch Institute in 2013.METHOD: Review of pertinent literature retrieved by a selective search in PubMed.RESULTS: Persons living in Germany generally acquire hepatitis E infection within the country by consuming infected and undercooked pork; in rare cases, hepatitis E infections are imported from the tropics. HEV can be transmitted via blood products, blood transfusions, and organ transplantation. More than 99% of HEV infections are asymptomatic and self-limiting, but there are also severe cases with acute liver failure. Immunosuppressed persons can develop chronic HEV infection, potentially leading, within a few years, to liver cirrhosis with life-threatening sequelae. Moreover, HEV infection may be associated with extrahepatic manifestations such as Guillain-Barré syndrome. In two retrospectively evaluated case series, ribavirin was found to be active against HEV and can be used to treat either acute or chronic HEV infection.CONCLUSION: Hepatitis E must be considered in the differential diagnosis of elevated hepatic enzyme levels and of systemic and neurological conditions of uncertain origin. The infection is usually self-limiting but can take a severe course in immunosuppressed persons. In such cases, ribavirin can be used as an antiviral treatment.

AB - BACKGROUND: At least 17% of the population in Germany has been infected with the hepatitis E virus (HEV); thus, HEV infections are more frequent than was previously assumed. However, fewer than 500 HEV infections were reported to the Robert Koch Institute in 2013.METHOD: Review of pertinent literature retrieved by a selective search in PubMed.RESULTS: Persons living in Germany generally acquire hepatitis E infection within the country by consuming infected and undercooked pork; in rare cases, hepatitis E infections are imported from the tropics. HEV can be transmitted via blood products, blood transfusions, and organ transplantation. More than 99% of HEV infections are asymptomatic and self-limiting, but there are also severe cases with acute liver failure. Immunosuppressed persons can develop chronic HEV infection, potentially leading, within a few years, to liver cirrhosis with life-threatening sequelae. Moreover, HEV infection may be associated with extrahepatic manifestations such as Guillain-Barré syndrome. In two retrospectively evaluated case series, ribavirin was found to be active against HEV and can be used to treat either acute or chronic HEV infection.CONCLUSION: Hepatitis E must be considered in the differential diagnosis of elevated hepatic enzyme levels and of systemic and neurological conditions of uncertain origin. The infection is usually self-limiting but can take a severe course in immunosuppressed persons. In such cases, ribavirin can be used as an antiviral treatment.

U2 - 10.3238/arztebl.2014.0577

DO - 10.3238/arztebl.2014.0577

M3 - SCORING: Zeitschriftenaufsatz

C2 - 25249359

VL - 111

SP - 577

EP - 583

JO - DTSCH ARZTEBL INT

JF - DTSCH ARZTEBL INT

SN - 1866-0452

IS - 35-36

ER -